Treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer
Description of the granted funding
In this project, we will investigate how targeted therapy in lung cancer influence the tumor immune response. Cancer cells that change during treatment may affect the tumor immune response. This could have a significant impact on treatment efficacy and the development of resistance. The project utilizes new mouse models and advanced single-cell techniques to comprehensively investigate the targeted therapy -induced changes in the tumor immune response in lung cancer, and to understand in detail the role of treatment-altered cancer cells in regulating the immune response. Our ultimate goal is to develop and test new ways to treat lung cancer.
Show moreStarting year
2025
End year
2029
Granted funding
Funder
Research Council of Finland
Funding instrument
Academy projects
Decision maker
Scientific Council for Biosciences, Health and the Environment
16.06.2025
16.06.2025
Other information
Funding decision number
370023
Fields of science
Biomedicine
Research fields
Biolääketieteet
Identified topics
cancer